{"id":392745,"date":"2020-12-03T09:03:36","date_gmt":"2020-12-03T14:03:36","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=392745"},"modified":"2020-12-03T09:03:36","modified_gmt":"2020-12-03T14:03:36","slug":"tuv-rheinland-notified-body-for-in-vitro-diagnostics","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/","title":{"rendered":"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <em>T\u00dcV Rheinland LGA Products GmbH is Notified Body for the EU Regulation on In Vitro Diagnostics (IVDR) 2017\/746 \/ Information at <\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Weu9LZ1pmVyc_L3QkSl9fUTQJ4w45Oq2LuQddy3ptamSLV_hQyv3UEG6N1btOwGPi8fTIfpDF3_JPNx3DEgpQimU6B4c8HIiffLPaS0haiA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <em><br \/>\n            <u>http:\/\/www.tuv.com\/en\/IVDR<\/u><br \/>\n          <\/em><br \/>\n        <\/a>\n      <\/p>\n<p>COLOGNE, Germany and LITTLETON, Mass., Dec.  03, 2020  (GLOBE NEWSWIRE) &#8212; T\u00dcV Rheinland LGA Products GmbH is Notified Body for the EU Regulation on In Vitro Diagnostics (IVDR) 2017\/746.<\/p>\n<p>\u201cWe are currently one of the few Notified Bodies worldwide for the new IVDR,\u201d says Dr. Wilma Hartung, Managing Director Medical Devices at T\u00dcV Rheinland.<\/p>\n<p>The IVDR regulation will replace the currently valid IVD Directive (98\/79\/EC) from 26 May 2022. The new regulation redefines the system for classifying products fundamentally. Manufacturers must now involve a Notified Body in the conformity assessment for a much larger number of in-vitro diagnostics. Information on the notification is available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6LbwHsZXUcjOgxdozPuMNu8dzW48C7UFl6E8hTzKwe-dMT4v8HBnbhoqS7UOhLpiY7lXdJiGrdbPve0qWB1tDr9733rknpnOgUW_MDyOOvbXz97haBJNstwVGpgCGojYkniYyDuBmf4P59uhPLrfZ67YgqMJME93jQryzMTSAFl8Z4WScNVEd4T_6FrZ6lYdHbOqEagUjwgQdq9BQ2Zsa_dNOrZob1Kd6iL04ezO_s0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>on the NANDO website of the European Union<\/u><\/a>. NANDO stands for \u201cNew Approach Notified and Designated Organisations.\u201d<\/p>\n<p>\n        <strong>A lot to be done until the IVDR becomes effective<\/strong><br \/>\n        <br \/>\u201cBy the time enforcement of the new regulation will begin in May 2022, the Notified Bodies will have to test a large number of in-vitro diagnostics manufacturers that are to be certified for the first time and with them a flood of technical documentation,\u201d explains Dr. Hartung. \u201cEven if the year 2022 still seems a long way off, we have already learned with the European Medical Device Directive MDR that manufacturers must adapt to the new requirements at a very early stage. This includes the early involvement of a Notified Body for the IVDR.\u201d<\/p>\n<p>With almost 40 years of experience in in-vitro diagnostic device assessments, T\u00dcV Rheinland is one of the most trusted independent testing service providers for major global brands. More information is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Weu9LZ1pmVyc_L3QkSl9fUTQJ4w45Oq2LuQddy3ptamQ7fWsNirdNx9E4x9yLF6naVPEEklvNQZsv-gGWCYOZ4uGPzks_wmXtZLdKMEWqe4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>http:\/\/www.tuv.com\/en\/IVDR<\/u><\/a> at T\u00dcV Rheinland.<\/p>\n<p>About TUV:<br \/>T\u00dcV Rheinland stands for safety and quality in virtually all areas of business and life. Founded almost 150 years ago, the company is one of the world\u2019s leading testing service providers with more than 20,000 employees and annual revenues of 2 billion euros. T\u00dcV Rheinland\u2019s highly qualified experts test technical systems and products around the world, support innovations in technology and business, train people in numerous professions and certify management systems according to international standards. In doing so, the independent experts generate trust in products as well as processes across global value-adding chains and the flow of commodities. Since 2006, T\u00dcV Rheinland has been a member of the United Nations Global Compact to promote sustainability and combat corruption. Website: <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wxsjU6TdWSApBqHiKFUBrzK_qndgY7i3LiKNKliNTe5_vnrBZN1LgVA08Y4bkmyU09_jgCU15UrMSDnieTgxxg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.tuv.com<\/a><\/u><\/p>\n<p>Contact for editorial questions: <br \/>Ralf Diekmann, T\u00dcV Rheinland, Press<br \/>Tel.: +49 (0)221\/806-1972<\/p>\n<p>Current press releases as well as photo and video footage are available on request by email to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fANtRTR5XE15AdJ0Qf8s37U6DtZfmyxZ2z5p8XCLM5Q0aepVsKfnoTRqGOFtcfOKiGbPegP72sj9WoQ06yE3Sg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>presse@de.tuv.com<\/u><\/a> or on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wxsjU6TdWSApBqHiKFUBr2T0PZ5fBA6PrS6ZFGtLPeOMc63hCJ6J41TSuphlG49zk1zuLFRAfmrJ2OfwkLYgMw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.tuv.com\/press<\/u><\/a>.<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/7d78912a-0883-496d-b9de-c13fde6eb226\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>T\u00dcV Rheinland LGA Products GmbH is Notified Body for the EU Regulation on In Vitro Diagnostics (IVDR) 2017\/746 \/ Information at http:\/\/www.tuv.com\/en\/IVDR COLOGNE, Germany and LITTLETON, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) &#8212; T\u00dcV Rheinland LGA Products GmbH is Notified Body for the EU Regulation on In Vitro Diagnostics (IVDR) 2017\/746. \u201cWe are currently one of the few Notified Bodies worldwide for the new IVDR,\u201d says Dr. Wilma Hartung, Managing Director Medical Devices at T\u00dcV Rheinland. The IVDR regulation will replace the currently valid IVD Directive (98\/79\/EC) from 26 May 2022. The new regulation redefines the system for classifying products fundamentally. Manufacturers must now involve a Notified Body in the conformity assessment for a much larger number of in-vitro diagnostics. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-392745","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"T\u00dcV Rheinland LGA Products GmbH is Notified Body for the EU Regulation on In Vitro Diagnostics (IVDR) 2017\/746 \/ Information at http:\/\/www.tuv.com\/en\/IVDR COLOGNE, Germany and LITTLETON, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) &#8212; T\u00dcV Rheinland LGA Products GmbH is Notified Body for the EU Regulation on In Vitro Diagnostics (IVDR) 2017\/746. \u201cWe are currently one of the few Notified Bodies worldwide for the new IVDR,\u201d says Dr. Wilma Hartung, Managing Director Medical Devices at T\u00dcV Rheinland. The IVDR regulation will replace the currently valid IVD Directive (98\/79\/EC) from 26 May 2022. The new regulation redefines the system for classifying products fundamentally. Manufacturers must now involve a Notified Body in the conformity assessment for a much larger number of in-vitro diagnostics. &hellip; Continue reading &quot;T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-03T14:03:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics\",\"datePublished\":\"2020-12-03T14:03:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/\"},\"wordCount\":459,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/\",\"name\":\"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==\",\"datePublished\":\"2020-12-03T14:03:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/","og_locale":"en_US","og_type":"article","og_title":"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics - Market Newsdesk","og_description":"T\u00dcV Rheinland LGA Products GmbH is Notified Body for the EU Regulation on In Vitro Diagnostics (IVDR) 2017\/746 \/ Information at http:\/\/www.tuv.com\/en\/IVDR COLOGNE, Germany and LITTLETON, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) &#8212; T\u00dcV Rheinland LGA Products GmbH is Notified Body for the EU Regulation on In Vitro Diagnostics (IVDR) 2017\/746. \u201cWe are currently one of the few Notified Bodies worldwide for the new IVDR,\u201d says Dr. Wilma Hartung, Managing Director Medical Devices at T\u00dcV Rheinland. The IVDR regulation will replace the currently valid IVD Directive (98\/79\/EC) from 26 May 2022. The new regulation redefines the system for classifying products fundamentally. Manufacturers must now involve a Notified Body in the conformity assessment for a much larger number of in-vitro diagnostics. &hellip; Continue reading \"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-03T14:03:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics","datePublished":"2020-12-03T14:03:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/"},"wordCount":459,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/","name":"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==","datePublished":"2020-12-03T14:03:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NTg2NyMzODUzOTgwIzUwMDAyNTQ0NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tuv-rheinland-notified-body-for-in-vitro-diagnostics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"T\u00dcV Rheinland: Notified Body for In-Vitro Diagnostics"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/392745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=392745"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/392745\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=392745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=392745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=392745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}